`
`
`
`
`
`
`
`Raymond N. Nimrod
`Isaac Nesser
`Nicola R. Felice
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`T: 212-849-7000
`
`John Yang
`QUINN, EMANUEL, URQUHART &
`SULLIVAN, LLP
`3100 McKinnon St, Suite 1125
`Dallas, TX 75201
`T: 469-902-3600
`
`Attorneys for Defendant Genevant
`Sciences GMBH
`
`Arnold B. Calmann
`Katherine A. Escanlar
`SAIBER LLC
`18 Columbia Turnpike, Suite 200
`Florham Park, NJ 07932
`(973) 622-3333
`abc@saiber.com
`kescanlar@saiber.com
`
`Attorneys for Defendants Arbutus Biopharma Corp. &
`Genevant Sciences GmbH
`
`Daralyn J. Durie
`Adam R. Brausa
`MORRISON & FOERSTER, LLP
`425 Market Street
`San Francisco, CA 94105-2482
`(415)268-7000
`ddurie@mofo.com
`abrausa@mofo.com
`
`Kira A. Davis
`MORRISON & FOERSTER LLP
`707 Wilshire Boulevard
`Los Angeles, CA 90017-3543
`(213)892-5200
`kiradavis@mofo.com
`
`
`
`Attorneys for Defendant Arbutus Biopharma Corp.
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`
`
`ACUITAS THERAPEUTICS INC.,
`
`
`
`
`
`ARBUTUS BIOPHARMA CORP. and GENEVANT
`SCIENCES GMBH,
`
`
`Plaintiffs,
`
`v.
`
`Defendants.
`
`Civil Action No. 3:23-4200-ZNQ-TJB
`
`DEFENDANTS’ NOTICE OF
`MOTION TO DISMISS PLAINTIFF
`ACUITAS THERAPEUTICS INC.’S
`COMPLAINT PURSUANT
`TO RULE 12(b)(1)
`
`
`Motion Date: November 6, 2023
`
`ORAL ARGUMENT REQUESTED
`
`Document Filed Electronically
`
`
`
`
`
`Case 3:23-cv-04200-ZNQ-TJB Document 13 Filed 10/13/23 Page 2 of 3 PageID: 751
`
`
`
`TO:
`
`All Counsel of Record
`
`
`
`PLEASE TAKE NOTICE that on Monday, November 6, 2023 at 10:00 a.m., or as soon
`
`thereafter as counsel may be heard, Defendants Arbutus Biopharma Corp. and Genevant Sciences
`
`GmbH (collectively, “Defendants”) shall appear before the Honorable Zahid N. Quraishi, U.S.D.J.
`
`at the Clarkson S. Fisher Building & U.S. Courthouse, 402 East State Street, Courtroom 4W,
`
`Trenton, New Jersey 08608, and shall move this Court for an Order dismissing Plaintiff Acuitas
`
`Therapeutics Inc.’s (“Plaintiff”) Complaint against them pursuant to Federal Rule of Civil
`
`Procedure 12(b)(1) for lack of subject matter jurisdiction.
`
`
`
`PLEASE TAKE FURTHER NOTICE that in support of their Motion, the Defendants
`
`shall rely upon their Brief, the Declaration of Nicola R. Felice (with exhibits), submitted
`
`concurrently herewith, any Reply papers to be submitted, and oral argument, if any. A proposed
`
`form of Order is also submitted for the Court’s consideration.
`
`Dated: October 13, 2023
`
`
`
`
`
`Respectfully submitted,
`
`
`Raymond N. Nimrod
`Isaac Nesser
`Nicola R. Felice
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`T: 212-849-7000
`
`John Yang
`QUINN, EMANUEL, URQUHART &
`SULLIVAN, LLP
`3100 McKinnon St, Suite 1125
`Dallas, TX 75201
`T: 469-902-3600
`
`Attorneys for Defendant Genevant
`Sciences GMBH
`
`
`
`s/ Arnold B. Calmann
`Arnold B. Calmann
`Katherine A. Escanlar
`SAIBER LLC
`18 Columbia Turnpike, Suite 200
`Florham Park, NJ 07932
`(973) 622-3333
`abc@saiber.com
`kescanlar@saiber.com
`
`Attorneys for Defendants Arbutus Biopharma Corp. &
`Genevant Sciences GmbH
`
`Daralyn J. Durie
`Adam R. Brausa
`MORRISON & FOERSTER, LLP
`425 Market Street
`San Francisco, CA 94105-2482
`(415)268-7000
`
`
`
`2
`
`
`
`Case 3:23-cv-04200-ZNQ-TJB Document 13 Filed 10/13/23 Page 3 of 3 PageID: 752
`
`
`
`
`
`ddurie@mofo.com
`abrausa@mofo.com
`
`Kira A. Davis
`MORRISON & FOERSTER LLP
`707 Wilshire Boulevard
`Los Angeles, CA 90017-3543
`(213)892-5200
`kiradavis@mofo.com
`
`Attorneys for Defendant Arbutus Biopharma Corp
`
`
`
`
`
`3
`
`